Antimicrobial resistance (AMR) is becoming one of the most serious public health challenges facing countries around the world and Nigeria is no exception. When bacteria viruses fungi and parasites stop responding effectively to medicines infections become more difficult and sometimes more expensive to treat. This can lead to longer hospital stays treatment failures and increased risks for patients. Understanding WHO Antimicrobial Resistance in Nigeria is therefore important for healthcare professionals policymakers communities and anyone who depends on effective medicines.

The World Health Organization (WHO) has been working with Nigeria and other countries to strengthen surveillance laboratory capacity antimicrobial stewardship and evidence-based policies. These efforts are designed to help Nigeria better understand resistance patterns and take action before resistant infections become even more difficult to control.

What Is Antimicrobial Resistance?

Antimicrobial resistance happens when microorganisms change over time and become less sensitive or resistant to medicines designed to kill or control them. Although antibiotic resistance is one of the most widely discussed forms of AMR resistance can also involve medicines used against fungi viruses and parasites.

AMR can develop naturally but inappropriate or unnecessary use of antimicrobial medicines can speed up the process. Taking antibiotics when they are not needed using the wrong medicine failing to follow a prescribed treatment plan and using antimicrobials without proper medical guidance can all contribute to the problem.

The consequences are not limited to individual patients. Resistant organisms can spread between people and communities making infection prevention and effective treatment a wider public health concern.

WHO Antimicrobial Resistance in Nigeria and the Importance of Surveillance

One of the most important parts of the global response to AMR is surveillance. Health authorities need reliable information about which microorganisms are becoming resistant where resistance is occurring and which medicines remain effective.

WHO's Global Antimicrobial Resistance and Use Surveillance System (GLASS) was created to support standardized collection and sharing of AMR and antimicrobial-use data. WHO describes surveillance as an essential tool for understanding resistance trends identifying emerging threats informing policies and measuring whether interventions are working.

For Nigeria stronger surveillance can provide a clearer picture of resistance across different regions and healthcare settings. It can also help laboratories doctors hospitals and policymakers make decisions based on evidence rather than assumptions.

In December 2025 Nigeria launched its first nationally representative AMR survey with support from WHO and partners. The initiative is intended to establish a national baseline for AMR prevalence understand the burden and distribution of resistance and strengthen routine surveillance and laboratory systems.

Strengthening Nigeria's AMR Response

Nigeria's response to antimicrobial resistance involves several organizations and sectors. The Nigeria Centre for Disease Control and Prevention (NCDC) Federal Ministry of Health and Social Welfare healthcare institutions laboratories academic organizations international partners and other stakeholders all have important roles.

The Nigerian National Antimicrobial Stewardship TaskForce (NNAST) also contributes to this national response by bringing together expertise and supporting antimicrobial stewardship activities. NNAST explains that its work includes supporting evidence-based AMR initiatives promoting responsible antibiotic use strengthening laboratory systems and supporting education and training.

WHO's involvement can help strengthen these efforts by providing technical guidance standardized approaches surveillance tools and international collaboration. The goal is not simply to collect numbers but to turn surveillance information into practical action.

For example if laboratory data show that a particular bacterial pathogen is becoming resistant to a commonly used antibiotic healthcare professionals can use that information to review treatment guidelines and improve prescribing decisions.

The Role of Antimicrobial Stewardship

Surveillance tells us what is happening while antimicrobial stewardship helps healthcare professionals respond responsibly.

Antimicrobial stewardship means using antimicrobial medicines appropriately. This includes selecting the right medicine dose route and duration when treatment is necessary. It also means avoiding antibiotics when an infection does not require them.

In Nigeria antimicrobial stewardship is especially important because access to medicines diagnostic services healthcare facilities and trained professionals can vary considerably between communities.

Effective stewardship can help preserve the medicines that still work. It can also reduce unnecessary exposure to antibiotics and improve patient safety.

Hospitals can strengthen stewardship by developing prescribing guidelines reviewing antibiotic use improving diagnostic testing monitoring resistance patterns and educating healthcare workers. Community awareness is equally important because patients also need to understand that antibiotics should not automatically be used for every fever cough or illness.

Laboratory Capacity Matters

Good AMR surveillance depends heavily on strong laboratories. Without reliable testing healthcare providers may have limited information about the microorganism causing an infection and whether it is resistant to particular medicines.

WHO-supported AMR initiatives in Nigeria have placed attention on improving laboratory and surveillance capacity. Nigeria's national AMR survey is also expected to strengthen diagnostics sample referral systems and laboratory capabilities as part of its broader objectives.

This is particularly important because laboratory results can help clinicians move away from unnecessary broad-spectrum antibiotic use and toward more targeted treatment when appropriate.

Nigeria's existing AMR laboratory guidance also emphasizes the importance of laboratory surveillance and antimicrobial susceptibility testing in understanding resistance.

Challenges Facing Nigeria

Despite important progress Nigeria still faces challenges in controlling AMR. These include limited diagnostic capacity in some settings differences in healthcare access inappropriate antimicrobial use gaps in surveillance coverage and the need for stronger coordination across sectors.

AMR is also a One Health issue. Human health animal health food production and the environment are connected. Resistant organisms can move between these areas meaning that efforts focused only on hospitals will not be enough.

Nigeria's earlier National Action Plan on AMR identified several weaknesses including limited resources gaps in implementation of guidelines and challenges in coordinating human and animal surveillance.

Addressing these issues requires sustained investment training better data systems effective regulation and cooperation among different sectors.

Why Public Awareness Is Important

The fight against AMR is not only the responsibility of doctors and government agencies. Members of the public also have an important role.

People should avoid buying or taking antibiotics without appropriate professional advice. They should not share antibiotics with family members or save leftover medicines for future illnesses. Most importantly people should understand that antibiotics do not treat viral infections such as many common colds and flu-like illnesses.

Simple public education can make a meaningful difference. When people understand why antimicrobial medicines should be used responsibly they are more likely to seek appropriate care and follow professional advice.

Looking Ahead

The future of WHO Antimicrobial Resistance in Nigeria depends on turning evidence into action. Strong surveillance reliable laboratories responsible prescribing antimicrobial stewardship infection prevention public education and effective policies must work together.

Nigeria's first nationally representative AMR survey represents an important step toward generating stronger national evidence. WHO's global surveillance systems also provide a framework for countries to collect standardized information and monitor progress against AMR.

For organizations such as NNAST supporting responsible antimicrobial use and strengthening stewardship remains an important part of this national effort. The challenge is significant but better data stronger collaboration and informed healthcare decisions can help protect the effectiveness of essential medicines.

Conclusion

WHO Antimicrobial Resistance in Nigeria highlights the importance of international cooperation in addressing one of the country's growing health challenges. Through surveillance technical support laboratory strengthening antimicrobial stewardship and evidence-based policies Nigeria can improve its ability to detect and respond to drug-resistant infections.

AMR cannot be solved by one organization or one intervention. It requires action from healthcare professionals laboratories policymakers communities and individuals. By using antimicrobial medicines responsibly today Nigeria can help ensure that effective treatments remain available for patients tomorrow.

For more information about antimicrobial resistance surveillance and stewardship in Nigeria explore the resources available through the Nigerian National Antimicrobial Stewardship TaskForce (NNAST).